Ask HopeStage to help me review this study
This study may no longer be open, but we can help you understand it and find similar studies.
Study ID: EUCTR 2021-003714-39. We help you review the study, but cannot decide medical eligibility.
Not recruitingEUCTR 2021-003714-39
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment in Subjects with Schizophrenia
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
SchizophreniaDrug
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Check recruitment and locations
EU CTR and CTIS records checked by HopeStage on . Registry information can change. Always confirm availability with the research team.
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
View the historical EU CTR record
Current CTIS country statuses
Historical EU CTR country statuses
- Bulgaria : Trial now transitioned
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Bulgaria · 18 sites
- MHAT Dr. Hristo Stambolski EOOD — Department of PsychiatryKazanlakCountry status: Not recruiting
- Medical Center Lifemed EOOD — NAKirdzhaliCountry status: Not recruiting
- State Psychiatric Hospital Lovech — Department for treatment of depressions, neurosesLovechCountry status: Not recruiting
- Medical Center Medconsult Pleven OOD — NAPlevenCountry status: Not recruiting
- University Multiprofile Hospital For Active Treatment Dr. Georgi Stranski EAD — First Psychiatric ClinicPlevenCountry status: Not recruiting
- Ambulatory For Group Practice For Specialized Psychiatric Help Philipopolis Ltd. — NAPlovdivCountry status: Not recruiting
- Medical Center Mentalcare Ltd. — NAPlovdivCountry status: Not recruiting
- Medical Center Spectar Plovdiv EOOD — NAPlovdivCountry status: Not recruiting
- University Multiprofile Hospital For Active Treatment Saint Georgi EAD — Clinic of PsychiatryPlovdivCountry status: Not recruiting
- Center For Mental Health Ruse EOOD — NARuseCountry status: Not recruiting
- Center For Mental Health Prof. N. Shipkovenski EOOD — NASofiaCountry status: Not recruiting
- Mental Health Center Sofia EOOD — NASofiaCountry status: Not recruiting
- Diagnostic And Consultation Centre St.Vrach And St.St. Kuzma And Damian OOD — NASofiyaCountry status: Not recruiting
- Medical Center Hera EOOD — NASofiyaCountry status: Not recruiting
- Medical Center Intermedica Ltd. — NASofiyaCountry status: Not recruiting
- Medical Center Saint Naum EOOD — NASofiyaCountry status: Not recruiting
- Center Za Psihichno Zdrave Veliko Tarnovo EOOD — Department of PsychiatryVeliko TarnovoCountry status: Not recruiting
- Center For Mental Health Vratsa EOOD — N/AVratsaCountry status: Not recruiting
Croatia · 8 sites
- Clinic for psychiatry Sveti Ivan — PsychiatryGrad ZagrebCountry status: Not recruiting
- KBC Zagreb — PsychiatryGrad ZagrebCountry status: Not recruiting
- KBC Zagreb — PsychiatryGrad ZagrebCountry status: Not recruiting
- KBC Zagreb — PsychiatryGrad ZagrebCountry status: Not recruiting
- Klinika za psihijatriju Vrapce — PsychiatryGrad ZagrebCountry status: Not recruiting
- Klinika za psihijatriju Vrapce — PsychiatryGrad ZagrebCountry status: Not recruiting
- Klinika za psihijatriju Vrapce — PsychiatryGrad ZagrebCountry status: Not recruiting
- Poliklinika Solmed d.o.o. — PsychiatryGrad ZagrebCountry status: Not recruiting
Czechia · 2 sites
- A-Shine s.r.o. — NAPlzen 3Country status: Not recruiting
- Neuropsychiatrie Petrska s.r.o. — NAPragueCountry status: Not recruiting
Romania · 12 sites
- Spitalul Clinic De Psihiatrie Si Neurologie Brasov — Psihiatrie IBrasovCountry status: Not recruiting
- Spitalul Clinic De Psihiatrie Si Neurologie Brasov — Psihiatrie IIBrasovCountry status: Not recruiting
- Centru De Evaluare Si Tratament A Toxicodependentelor Pentru Tineri Sf. Stelian — PsihiatrieBucharestCountry status: Not recruiting
- Spitalul Clinic De Psihiatrie Prof.Dr.Alexandru Obregia — Centrul de Sanatate MintalaBucharestCountry status: Not recruiting
- Spitalul Clinic De Psihiatrie Prof.Dr.Alexandru Obregia — Sectia Clinica Psihiatrie IIIBucharestCountry status: Not recruiting
- Spitalul Clinic De Psihiatrie Prof.Dr.Alexandru Obregia — Sectia Clinica Psihiatrie XIIBucharestCountry status: Not recruiting
- Institutul Privat de Cercetari Melchisedec, pentru Boli Autoimune, Ereditare si Rare - IPCM — PsihiatrieCraiovaCountry status: Not recruiting
- Institutul De Psihiatrie Socola Iasi — Psihiatrie III AcutiJassiCountry status: Not recruiting
- Institutul De Psihiatrie Socola Iasi — Psihiatrie V AcutiJassiCountry status: Not recruiting
- Spitalul Clinic Judetean De Urgenta Bihor — Psihiatrie 2OradeaCountry status: Not recruiting
- Mediab S.R.L. — PsihiatrieTargu MuresCountry status: Not recruiting
- Spitalul Clinic Judetean Mures — Clinica Psihiatrie ITargu MuresCountry status: Not recruiting
Slovakia · 7 sites
- Dana Ignjatovičová, spol. s.r.o., — N/ABanská BystricaCountry status: Not recruiting
- Nemocnica S Poliklinikou Prievidza So Sidlom V Bojniciach — Psychiatricke oddelenieBojniceCountry status: Not recruiting
- Univerzitna nemocnica L. Pasteura Kosice — II. Psychiatricka klinikaKosiceCountry status: Not recruiting
- Penta Hospitals SK a.s. — Psychiatricke oddelenieRimavska SobotaCountry status: Not recruiting
- PsychoLine s.r.o. — N/ARimavska SobotaCountry status: Not recruiting
- Mentum s.r.o. — N/AStare MestoCountry status: Not recruiting
- Crystal Comfort s.r.o. — N/AVranov Nad ToplouCountry status: Not recruiting
Spain · 5 sites
- Hospital De La Santa Creu I Sant Pau — PsychiatryBarcelonaCountry status: Not recruiting
- Hospital Universitario Reina Sofia — PsychiatryCordobaCountry status: Not recruiting
- Hospital Universitario Ramon Y Cajal — PsychiatryMadridCountry status: Not recruiting
- Parc Tauli Hospital Universitari — PsychiatrySabadellCountry status: Not recruiting
- University Hospital Virgen Del Rocio S.L. — PsychiatrySevillaCountry status: Not recruiting
Key information made simple
What the source confirms
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
What should you check before joining?
Check the official protocol for eligibility, treatment, visits and assessments. If recruitment is listed, confirm with the team that a specific centre is still accepting participants before taking any next step.
Your next step
Study sites are listed in the registry. Recruitment status can differ between sites. Ask the research team to confirm the location, any in-person visits, time commitment, costs or compensation, and participation criteria.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- 400
- Sponsor
- Neurocrine Biosciences, Inc.
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Bulgaria, Croatia, Czechia, ...
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2021-003714-39
- Official title
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment in Subjects with Schizophrenia
- Official source
- Official registry link
Ask HopeStage to help me review this study
This study may no longer be open, but we can help you understand it and find similar studies.
Study ID: EUCTR 2021-003714-39. We help you review the study, but cannot decide medical eligibility.
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What does the official source confirm?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Is this study recruiting?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
How can I check the participation requirements?
Check the official protocol for the criteria, treatment and planned assessments. The research team must confirm visits, risks, open centres and your eligibility.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
Not recruitingEUCTR 2018-004590-27
2-year, Multicentre, Open-label, Flexible-dose Study to Evaluate the Safety and Tolerability of Cariprazine in the Treatment of Adolescent Patients with Schizophrenia
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Not recruitingEUCTR 2008-002676-10
A 38-week, Multicenter, Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Mai...
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Not recruitingEUCTR 2008-002699-83
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients with Schizophrenia "ASPIRE OPEN-LABEL" (Aripiprazole...
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.